Wolters Kluwer strengthens Clinical GenAI market leadership with AI Labs powered by UpToDate

Relentless innovation in Clinical GenAI  

UpToDate’s AI Lab has established core capabilities from verbatim UpToDate passage retrieval to AI-synthesized responses based exclusively on UpToDate’s unparalleled content.  

By asking natural language questions, AI Labs’ capabilities deliver targeted answers derived exclusively from UpToDate’s continually updated content, avoiding the pitfalls of outdated or superseded evidence. Further, AI Labs remembers query context and provides relevant evidence citations.  

Collaborating with customers for safer, more transparent GenAI

Discussing the potential of GenAI for healthcare, Eric Alper, MD, Senior Vice President, Chief Quality Officer, and Chief Clinical Informatics Officer at UMass Memorial Health stated: “UpToDate has long provided clinicians with the information they need to make clinical decisions. From what I’ve seen, the combination of UpToDate with GenAI through AI Labs could get clinicians to expert, succinct, evidenced-based content even faster.”

Customers play a valuable role in the ongoing development of AI Labs. Julio Ramirez, MD, Chief Scientific Officer at Norton Infectious Diseases Institute commented, “I’ve provided feedback to Wolters Kluwer on AI Labs since last year. I’m impressed with their approach and the progress they have made on the responsible use of Gen AI in clinical decision support. With the entire UpToDate content set now in AI Labs, as well as expanded access to the testing and validation program by more clinicians, there is the opportunity to accelerate the use of Gen AI in clinical decision support.”

When seconds count, GenAI can aid in clinicians finding answers more quickly. Patrick Snowman, MD, Chief, Department of Medicine at Hilton Head Regional Health explains: “In the Emergency Department, time is of the essence.  It is imperative to have a solution like UpToDate to quickly access vital information that supports clinical care. I look forward to testing and validating that GenAI, when combined with UpToDate, offers the ability to get faster and more concise answers in support of delivering better care.”

In recognition of the company’s approach to GenAI, Wolters Kluwer Health was recently named a healthcare technology pioneer for GenAI in clinical settings by industry analysts at Frost & Sullivan.

AI Labs will be demonstrated at the Wolters Kluwer booth, #2927, at the HIMSS24 Global Conference and Exhibition. Watch this video to learn more about Wolters Kluwer’s mission for Clinical GenAI.